MEDI FUTURES
Have updates for this profile? Please contribute data
= Subscriber Access Only
You are viewing a preview of this profile. Request a Preqin Pro demo for full access to all profiles and underlying data.
With Preqin Pro, you gain an unobstructed view of all alternative asset class activity across institutional investors, fund managers, funds, portfolio companies, deals, exits, and service providers.
MEDI FUTURES - overview
Established
2016
Location
Seongnam, Gyeonggi-do, South Korea
Primary Industry
Healthcare
About
MEDI FUTURES Co. Ltd. , based in Seongnam, South Korea, specializes in healthcare solutions utilizing advanced ultrasonic technology to enhance surgical precision and efficiency while also focusing on regenerative medicine and consumer healthcare products. Founded in 2016 in Seongnam, South Korea, MEDI FUTURES is dedicated to providing innovative healthcare solutions.
The company raised KRW 1 billion in venture funding from The Wells Investment on September 26, 2023. Jimin Kim serves as the CEO, bringing prior entrepreneurial experience to the role. MEDI FUTURES specializes in innovative healthcare solutions that leverage advanced ultrasonic technology. Core offerings include medical devices designed for surgical applications that enhance precision during procedures, alongside developments in regenerative medicine, particularly utilizing adipose-derived stem cells.
The consumer healthcare segment features brands like Rbfy Cosmetics and Ohpily Foods, aimed at enhancing overall well-being. Products are marketed primarily in South Korea, with plans to expand internationally to serve a diverse clientele of healthcare professionals and consumers. MEDI FUTURES generates revenue through direct sales and partnerships in the healthcare sector, engaging in B2B transactions with hospitals and medical institutions. Their offerings involve unique pricing structures based on product specifications.
The consumer healthcare segment operates on a direct-to-consumer basis, allowing access to wellness products through retail channels. Specific individual product pricing plans remain undisclosed, supporting continuous innovation in both medical and consumer healthcare sectors. Following the recent funding of KRW 1 billion, MEDI FUTURES plans to establish a research institute and commercialize three additional products. The company is looking to expand into new international markets, enhancing its global presence.
These strategies will be supported through the effective deployment of the recently secured funding.
Current Investors
Samho Green Investment, ST Capital, Korea Credit Guarantee Fund
Primary Industry
Healthcare
Sub Industries
Beauty & Hygiene, Healthcare, Medical Devices & Equipment, Biomaterials
Website
www.medifutures.net
Verticals
E-commerce, Manufacturing
Company Stage
Early Stage
Total Amount Raised
Subscriber access only
MEDI FUTURES - employee data
Time to go Pro
Get Preqin Pro for unrestricted access to 600,000+ detailed profiles on fund managers, investors, funds, companies, and other alternative asset players. Unlock exclusive data on future plans, company financials, fundraising history, track records, and more.